FARMINGTON, Conn., Nov. 5, 2012 /PRNewswire-iReach/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion.
From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research partner BioPharm Reports,, is offering a special discount on all BioPharm market research reports, forecasts, and studies. How will your organization use the critical information contained within these reports to support growth and sales strategies and seize market opportunities in the life sciences field?
Life Science Software: Markets and Opportunities
This report is the result of six life science studies examining the use of specialist software and databases related to the conduct of PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarker studies. In total, 2,200 end-users in 70 countries participated in these studies. This is an excellent study for software developers and vendors to identify market opportunities in the life science field.
The major components of the report are as follows: breakdown of end-user practices in use of life science software and databases to conduct studies of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry, and disease biomarker; breakdown of end-user practices by field (e.g. biotech, hospital, defence, pharmaceuticals, food and drink); breakdown by region, including Europe, North Americ
|SOURCE Global Information, Inc.|
Copyright©2012 PR Newswire.
All rights reserved